Wire Stories
-
5922021 China-Baltic States Wushu Online Competition Concluded Successfully
BEIJING–(BUSINESS WIRE)–#ChineseMartialArts–On November 28, 2021 Beijing time, after 6 days of assessment, the 2021 China-Baltic States Wushu Online Competition came to an...
-
714
Tech Mahindra Launches FiDaaS Solution Powered by Alveo to Address Financial Services� Data Management Challenges
The highly scalable solution will help financial institutions meet their risk management, valuation, security master and operational needs AMSTERDAM, Netherlands–(BUSINESS WIRE)–#Alveo—Tech Mahindra,...
-
660
Airtel Inks Deal with Juniper Networks to Further Expand Broadband Network Coverage Across India
NEW DELHI–(BUSINESS WIRE)–Juniper Networks (NYSE: JNPR), a leader in secure, AI-driven networks, today announced that it has been selected by Bharti Airtel...
-
599
Visa Introduces Crypto Advisory Services to Help Partners Navigate a New Era of Money Movement
The case for crypto is getting stronger for financial institutions; new global research finds nearly 40% of crypto owners would be likely...
-
548
CR2 Continues to Drive Innovation as Cardless ATM Access Goes Live in Eight Countries
DUBLIN–(BUSINESS WIRE)–#CR2—It�s a major concern for banking customers worldwide in this time of a global pandemic – how can they access their...
-
564
APRU Metagame Conference 2021 Returns at Cyberport�s Annual Digital Entertainment Leadership Forum
HONG KONG–(BUSINESS WIRE)–#HigherEducation–In partnership with Cyberport, the 2nd Association of Pacific Rim Universities (APRU) Metagame Conference will take place within a broader...
-
791
Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID
DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2 Significantly fewer patients in the fidaxomicin group...
-
638
Tillotts Pharma AG announces that DIFICLIRTM (fidaxomicin) is recommended for the treatment of Clostridioides difficile infection (CDI) by ESCMID
DIFICLIRTM (fidaxomicin) is now recommended as first-line CDI treatment in both European and U.S. guidelines1,2 Significantly fewer patients in the fidaxomicin group...
-
619
NCEC and OURAY Announce Integrated Emergency Response Support for the Global Market
Organisations across the world will be able to access an integrated emergency response service now that NCEC has signed a distributor agreement...
-
552
Power Integrations� New InnoSwitch3-TN ICs Slash Energy Waste in Appliance Power Supplies by 75%
Beyond the buck regulator: Newest InnoSwitch3 IC family delivers simplicity, flexibility, and industry-leading efficiency in high-output-current designs SAN JOSE, Calif.–(BUSINESS WIRE)–Power Integrations...
